Pacer Advisors, Inc. Merck & Co., Inc. Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 196,465 shares of MRK stock, worth $19.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

196,465

Previous 199,829 1.68%

Holding current value

$19.3 Million

Previous $24.7 Million 9.81%

% of portfolio

0.05%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $373,908 - $433,855	-3,364 Reduced 1.68%	196,465 $22.3 Million
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $945,955 - $1.02 Million	7,641 Added 3.98%	199,829 $24.7 Million
Q1 2024 May 10, 2024	SELL	$113.24 - $131.95 $5.62 Million - $6.54 Million	-49,593 Reduced 20.51%	192,188 $25.4 Million
Q4 2023 Jan 16, 2024	BUY	$100.18 - $109.02 $7.16 Million - $7.8 Million	71,517 Added 42.0%	241,781 $26.4 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $487,365 - $541,238	4,734 Added 2.86%	170,264 $17.5 Million
Q2 2023 Jul 12, 2023	BUY	$108.61 - $118.38 $536,098 - $584,323	4,936 Added 3.07%	165,530 $19.1 Million
Q1 2023 May 02, 2023	BUY	$102.94 - $114.86 $4.32 Million - $4.82 Million	41,987 Added 35.4%	160,594 $17.1 Million
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $9.03 Million - $11.6 Million	103,244 Added 672.03%	118,607 $13.2 Million
Q3 2022 Oct 18, 2022	BUY	$84.53 - $94.96 $84,699 - $95,149	1,002 Added 6.98%	15,363 $1.32 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $15.5 Million - $17.6 Million	-185,877 Reduced 92.83%	14,361 $1.31 Million
Q1 2022 Apr 05, 2022	BUY	$73.51 - $82.4 $2 Million - $2.25 Million	27,250 Added 15.75%	200,238 $16.4 Million
Q4 2021 Feb 03, 2022	SELL	$72.28 - $90.54 $549,617 - $688,466	-7,604 Reduced 4.21%	172,988 $13.3 Million
Q3 2021 Oct 15, 2021	BUY	$71.68 - $78.83 $1.55 Million - $1.71 Million	21,658 Added 13.63%	180,592 $13.6 Million
Q2 2021 Jul 21, 2021	BUY	$70.31 - $77.77 $1.15 Million - $1.27 Million	16,332 Added 11.45%	158,934 $12.4 Million
Q1 2021 Apr 05, 2021	SELL	$68.86 - $81.11 $663,121 - $781,089	-9,630 Reduced 6.33%	142,602 $11 Million
Q4 2020 Jan 20, 2021	SELL	$71.77 - $79.65 $2.61 Million - $2.9 Million	-36,412 Reduced 19.3%	152,232 $12.5 Million
Q3 2020 Oct 19, 2020	SELL	$73.18 - $82.95 $2.25 Million - $2.55 Million	-30,734 Reduced 14.01%	188,644 $15.6 Million
Q2 2020 Jul 29, 2020	BUY	$70.42 - $80.13 $15.4 Million - $17.5 Million	218,480 Added 24329.62%	219,378 $17 Million
Q1 2020 Apr 23, 2020	BUY	$63.36 - $87.82 $8,870 - $12,294	140 Added 18.47%	898 $75,000
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $21.4 Million - $24.2 Million	-276,041 Reduced 99.73%	758 $69,000
Q3 2019 Oct 10, 2019	BUY	$76.08 - $82.93 $2.1 Million - $2.29 Million	27,592 Added 11.07%	276,799 $23.3 Million
Q2 2019 Aug 12, 2019	BUY	$69.84 - $81.59 $1.14 Million - $1.33 Million	16,361 Added 7.03%	249,207 $20.9 Million
Q1 2019 Apr 10, 2019	BUY	$69.58 - $79.36 $16.1 Million - $18.4 Million	232,072 Added 29983.46%	232,846 $19.4 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $9.29 Million - $10.8 Million	-142,378 Reduced 99.46%	774 $59,000
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $992,498 - $1.17 Million	17,204 Added 13.66%	143,152 $10.2 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $1.12 Million - $1.31 Million	21,982 Added 21.14%	125,948 $7.65 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $593,429 - $689,733	11,645 Added 12.61%	103,966 $5.66 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $384,827 - $459,526	-7,455 Reduced 7.47%	92,321 $5.2 Million
Q3 2017 Nov 08, 2017	BUY	$58.67 - $63.13 $5.85 Million - $6.3 Million	99,776	99,776 $6.39 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Merck & Co., Inc. Transaction History